MU Remembers honors lives of students, faculty and staff
Event recognizes contributions of classmates and peers.
ABK Biomedical and MURR forge long-term partnership to advance breakthrough cancer therapy
A new agreement names MURR as the primary irradiation partner for ABK Biomedical's Eye90 microspheres.
DOE and MURR secure critical radioisotope supply chain for medical imaging
The University of Missouri Research Reactor is now the only domestic supplier of gadolinium-153 through a new agreement with the Department of Energy.
March 18, 2026
NextGen MURR teams with Burns & McDonnell, supporting the future of lifesaving nuclear medical isotope production
The drive to build a new state-of-the-art research reactor at Mizzou continues as a major milestone is reached.
March 10, 2026
MURR makes NCA Lu-177 available worldwide
Expanded supply will enable researchers and industry to purchase GMP no-carrier-added Lutetium-177 directly from the reactor.
Feb. 10, 2026
University of Missouri conducts first in-person clinical trial for nuclear medicine breakthrough device
The clinical trial marks the latest human trial at Mizzou involving radioisotopes to treat cancer.
Dec. 17, 2025
Mizzou thrived in 2025
Relive some of the University of Missouri’s most notable moments of 2025.
Nov. 12, 2025
A look at Mizzou by the numbers
The University of Missouri is a broad and dynamic community, connected by a common mission and the facts that reflect who we are. Here’s a look at the numbers that drive our impact.
Oct. 28, 2025
University leaders and Korean alumni convene for 16th Harry S. Truman Conference
The Missouri delegation also toured leading engineering and energy facilities.
Sep. 9, 2025
Mizzou researchers unleash the power of a new tool in canine cancer treatment
The College of Veterinary Medicine study analyzed radioactive iodine therapy for treatment of thyroid cancer in dogs.